Breaking News Instant updates and real-time market news.

NTES

NetEase

$266.00

-0.26 (-0.10%)

08:45
05/17/18
05/17
08:45
05/17/18
08:45

NetEase price target lowered to $340 from $355 at Benchmark

Benchmark analyst Fawne Jiang lowered her price target on NetEase to $340 from $355, citing near-term margin pressure following the company's report of mixed Q1 results. While its revenue beat was mainly driven by the resumption of mobile gaming growth and continued momentum of the ecommerce businesses, NetEase's earnings underperformance was mainly due to higher operating expenses and higher copyrights related costs, said Jiang, who keeps a Buy rating on the stock.

NTES NetEase
$266.00

-0.26 (-0.10%)

04/05/18
DBAB
04/05/18
NO CHANGE
Target $347
DBAB
Buy
NetEase price target lowered to $347 from $365 at Deutsche Bank
Deutsche Bank analyst Han Joon Kim lowered his price target for NetEase to $347 ahead of the company's Q1 results. Given the recent pullback in the shares, the Q1 "earnings trough could represent a tactical entry point," Kim tells investors in a research note. He says that while the company "is still lacking in the new pipeline area," he does see high visibility of sequential recovery beyond Q1 amid new game launches and improved monetization of sandbox shooting games. The analyst keeps a Buy rating on NetEase.
04/10/18
JEFF
04/10/18
NO CHANGE
Target $310
JEFF
Hold
NetEase price target lowered to $310 from $335 at Jefferies
Jefferies analyst Karen Chan lowered her price target for NetEase to $310 from $335, while reiterating a Hold rating on the shares. The analyst remains long-term positive on its gaming franchise and expects mobile games to resume quarter over quarter growth in Q1, but notes she will need further evidence of either more new hits or newly-launched titles performing better in order to justify upside to her 20% FY18 mobile game growth forecast. Rising competition for gamer time spent, increased promotional effort and revenue mix change poses downside risk to FY18/19 consensus earnings, Chan contends.
04/12/18
JPMS
04/12/18
INITIATION
Target $240
JPMS
Underweight
NetEase resumed with an Underweight at JPMorgan
JPMorgan analyst Alex Yao resumed coverage of NetEase with an Underweight rating and $240 price target. Prior to restricting the stock in 2016, the firm had an Overweight rating on the shares. The analyst views 2018 as a transition year for NetEase in terms of game genre and geographic market. The biggest revenue driver of NetEase in the past few years, PC IP migration to mobile, "has already been exhausted," Yao tells investors in a research note. He believes NetEase is entering a "structurally less profitable stage" due to lower per gamer monetization.
04/25/18
LYON
04/25/18
UPGRADE
LYON
Outperform
NetEase upgraded to Outperform from Underperform at CLSA
CLSA upgraded NetEase to Outperform from Underperform, mainly citing valuation, adding that the company could see a rebound in gaming revenues in Q1.

TODAY'S FREE FLY STORIES

MLHR

Herman Miller

$37.30

0.2 (0.54%)

08:12
09/20/18
09/20
08:12
09/20/18
08:12
Technical Analysis
Technical Take: Herman Miller nears 52-week high after stronger results, outlook »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MANT

ManTech

$62.05

-2.62 (-4.05%)

08:09
09/20/18
09/20
08:09
09/20/18
08:09
Hot Stocks
ManTech an awardee on $28B AFICA contract »

ManTech announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$55.59

-8.59 (-13.38%)

08:09
09/20/18
09/20
08:09
09/20/18
08:09
Recommendations
Copart analyst commentary  »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$43.27

-0.25 (-0.57%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Hot Stocks
Pfizer granted FDA Breakthrough Therapy designation for 20vPnC »

Pfizer announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

HCA

HCA Healthcare

$131.92

-1.86 (-1.39%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Recommendations
HCA Healthcare analyst commentary  »

HCA Healthcare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.82

-0.07 (-2.42%)

, CELG

Celgene

$87.39

-0.22 (-0.25%)

08:06
09/20/18
09/20
08:06
09/20/18
08:06
Hot Stocks
Celgene will not exercise option to license OncoMed's navicixizumab »

OncoMed (OMED) announced…

OMED

OncoMed

$2.82

-0.07 (-2.42%)

CELG

Celgene

$87.39

-0.22 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 29

    Oct

MO

Altria Group

$61.83

-0.31 (-0.50%)

, BTI

British American Tobacco

$46.87

-0.475 (-1.00%)

08:05
09/20/18
09/20
08:05
09/20/18
08:05
Recommendations
Altria Group, British American Tobacco, Philip Morris analyst commentary  »

Tobacco stocks to rally…

MO

Altria Group

$61.83

-0.31 (-0.50%)

BTI

British American Tobacco

$46.87

-0.475 (-1.00%)

PM

Philip Morris

$80.92

0.59 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

SNHY

Helios Technologies

$55.00

0.49 (0.90%)

08:05
09/20/18
09/20
08:05
09/20/18
08:05
Upgrade
Helios Technologies rating change  »

Helios Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

ZG

Zillow

$43.78

-0.37 (-0.84%)

, Z

Zillow

$44.12

-0.49 (-1.10%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Hot Stocks
Zillow signs listings agreement with Right at Home Realty »

Zillow announced that…

ZG

Zillow

$43.78

-0.37 (-0.84%)

Z

Zillow

$44.12

-0.49 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIB

CGI Group

$66.11

(0.00%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Hot Stocks
CGI Group acquires ckc AG in Germany »

CGI announce its merger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$24.50

0.8 (3.38%)

08:04
09/20/18
09/20
08:04
09/20/18
08:04
Upgrade
Manitowoc rating change  »

Manitowoc upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$34.89

0.01 (0.03%)

08:03
09/20/18
09/20
08:03
09/20/18
08:03
Downgrade
Bruker rating change  »

Bruker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

PSMT

PriceSmart

$83.60

-0.9 (-1.07%)

08:03
09/20/18
09/20
08:03
09/20/18
08:03
Hot Stocks
PriceSmart acquires land in Guatemala »

PriceSmart announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

WFC

Wells Fargo

$55.23

0.73 (1.34%)

08:01
09/20/18
09/20
08:01
09/20/18
08:01
Periodicals
Wells Fargo denies New York Post report on Cohn approach, CNBC says »

Wells Fargo is denying a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

RHT

Red Hat

$143.38

0.59 (0.41%)

08:00
09/20/18
09/20
08:00
09/20/18
08:00
Recommendations
Red Hat analyst commentary  »

Red Hat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$31.01

0.79 (2.61%)

08:00
09/20/18
09/20
08:00
09/20/18
08:00
Options
Bank of America call buyer realizes 319% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 27

    Sep

DRI

Darden

$117.90

-1.03 (-0.87%)

07:59
09/20/18
09/20
07:59
09/20/18
07:59
Technical Analysis
Technical Take: Darden hits new life high after results »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 11

    Oct

FBP

First BanCorp

$8.61

0.12 (1.41%)

07:59
09/20/18
09/20
07:59
09/20/18
07:59
Upgrade
First BanCorp rating change  »

First BanCorp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

XOMA

Xoma

$16.05

-0.15 (-0.93%)

07:58
09/20/18
09/20
07:58
09/20/18
07:58
Conference/Events
Xoma management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

SQ

Square

$84.81

-3.16 (-3.59%)

07:58
09/20/18
09/20
07:58
09/20/18
07:58
Recommendations
Square analyst commentary  »

Square price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 26

    Nov

NWL

Newell Brands

$21.64

0.125 (0.58%)

07:57
09/20/18
09/20
07:57
09/20/18
07:57
Recommendations
Newell Brands analyst commentary  »

Wells sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLH

William Lyon Homes

$18.64

-0.68 (-3.52%)

07:55
09/20/18
09/20
07:55
09/20/18
07:55
Downgrade
William Lyon Homes rating change  »

William Lyon Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$80.01

0.595 (0.75%)

07:55
09/20/18
09/20
07:55
09/20/18
07:55
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WHLR

Wheeler REIT

$4.18

0.03 (0.72%)

07:54
09/20/18
09/20
07:54
09/20/18
07:54
Hot Stocks
Wheeler REIT reports minimal damage from Hurricane Florence »

Wheeler REIT announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$152.78

3.63 (2.43%)

07:54
09/20/18
09/20
07:54
09/20/18
07:54
Upgrade
Caterpillar rating change  »

Baird sees demand growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.